The formation of G4s in these key regulatory regions, such as those found in c-MYC, KRAS, and others, has been associated with reduced gene expression, further suggesting that targeting these G4 structures could serve as an effective approach for anti-cancer therapies [93,94]. The gene discussed is KRAS; the disease is cancer.